LIVN vs. ITGR, CNMD, HAE, TMDX, INMD, SLNO, BLFS, AXGN, OM, and MASI
Should you be buying LivaNova stock or one of its competitors? The main competitors of LivaNova include Integer (ITGR), CONMED (CNMD), Haemonetics (HAE), TransMedics Group (TMDX), InMode (INMD), Soleno Therapeutics (SLNO), BioLife Solutions (BLFS), AxoGen (AXGN), Outset Medical (OM), and Masimo (MASI). These companies are all part of the "medical" sector.
Integer (NYSE:ITGR) and LivaNova (NASDAQ:LIVN) are both mid-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, community ranking, media sentiment, valuation, profitability, risk, analyst recommendations, dividends and institutional ownership.
Integer has a net margin of 6.01% compared to Integer's net margin of -2.68%. Integer's return on equity of 13.59% beat LivaNova's return on equity.
Integer currently has a consensus price target of $128.00, suggesting a potential upside of 5.47%. LivaNova has a consensus price target of $66.20, suggesting a potential upside of 9.48%. Given Integer's higher possible upside, analysts plainly believe LivaNova is more favorable than Integer.
In the previous week, Integer and Integer both had 5 articles in the media. Integer's average media sentiment score of 1.16 beat LivaNova's score of 0.83 indicating that LivaNova is being referred to more favorably in the news media.
99.3% of Integer shares are owned by institutional investors. Comparatively, 97.6% of LivaNova shares are owned by institutional investors. 2.0% of Integer shares are owned by company insiders. Comparatively, 0.3% of LivaNova shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
LivaNova received 3 more outperform votes than Integer when rated by MarketBeat users. Likewise, 68.78% of users gave LivaNova an outperform vote while only 63.41% of users gave Integer an outperform vote.
Integer has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500. Comparatively, LivaNova has a beta of 0.92, meaning that its share price is 8% less volatile than the S&P 500.
Integer has higher revenue and earnings than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.
Summary
Integer beats LivaNova on 10 of the 17 factors compared between the two stocks.
Get LivaNova News Delivered to You Automatically
Sign up to receive the latest news and ratings for LIVN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LIVN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip ChartThis chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
LivaNova Competitors List
Related Companies and Tools